rolipram has been researched along with (pPNET) Peripheral Primitive Neuroectodermal Tumors in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dose-response experiments in clonal density conditions showed IC50 of 5 microM and 1." | 1.30 | Phosphodiesterase specific inhibitors control cell growth of a human neuroepithelioma cell line. ( Augusti-Tocco, G; Campagnolo, L; Giorgi, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campagnolo, L | 1 |
| Giorgi, M | 1 |
| Augusti-Tocco, G | 1 |
1 other study available for rolipram and (pPNET) Peripheral Primitive Neuroectodermal Tumors
| Article | Year |
|---|---|
Phosphodiesterase specific inhibitors control cell growth of a human neuroepithelioma cell line.
Topics: Cell Division; Humans; Neuroectodermal Tumors, Primitive, Peripheral; Phosphodiesterase Inhibitors; | 1997 |